CHG-2022-0143

Analytical Method Change for Upadacitimab. Facility Change for Upadacitimab — routine update. Impacts 4 markets and 2 variations.

Change Number
CHG-2022-0143
Type
Analytical Method Change
Product
Upadacitimab
Status
Approved
Owner
Nadia Petrova
Initiated
2023-02-08
Description

Facility Change for Upadacitimab — routine update

Impacted Markets (4)
AU — AustraliaGB — United KingdomPL — PolandBE — Belgium
Impacted Modules
2.3.P3.2.P5.3.53.2.P.3
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved